We just received data on a new analyst forecast for $PRCT. Danielle Antalffy from UBS set a price target of 62.0 for PRCT.
To track analyst ratings and price targets for $PRCT, check out Quiver Quantitative's $PRCT forecast page.
Should you buy $PRCT?
Some analysts are better than others. To view the past performance of UBS, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$PRCT Price Targets
Multiple analysts have issued price targets for $PRCT recently. We have seen 8 analysts offer price targets for $PRCT in the last 6 months, with a median target of $50.5.
Here are some recent targets:
- Danielle Antalffy from UBS set a target price of $62.0 on 12/12/2025
- Craig Bijou from B of A Securities set a target price of $38.0 on 12/08/2025
- Patrick Wood from Morgan Stanley set a target price of $51.0 on 12/02/2025
- Matt O'Brien from Piper Sandler set a target price of $50.0 on 11/05/2025
- Nathan Treybeck from Wells Fargo set a target price of $51.0 on 11/05/2025
- Joshua Jennings from TD Cowen set a target price of $50.0 on 11/05/2025
- Richard Newitter from Truist Securities set a target price of $50.0 on 10/15/2025
$PRCT Insider Trading Activity
$PRCT insiders have traded $PRCT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $PRCT stock by insiders over the last 6 months:
- FREDERIC H MOLL purchased 20,000 shares for an estimated $785,138
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PRCT Revenue
$PRCT had revenues of $83.3M in Q3 2025. This is an increase of 42.76% from the same period in the prior year.
You can track PRCT financials on Quiver Quantitative's PRCT stock page.
$PRCT Hedge Fund Activity
We have seen 132 institutional investors add shares of $PRCT stock to their portfolio, and 162 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. added 1,262,928 shares (+58.6%) to their portfolio in Q3 2025, for an estimated $45,073,900
- CHICAGO CAPITAL, LLC added 999,873 shares (+175.7%) to their portfolio in Q3 2025, for an estimated $35,685,467
- AXA S.A. removed 850,490 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,353,988
- ARROWMARK COLORADO HOLDINGS LLC added 786,094 shares (+229.7%) to their portfolio in Q3 2025, for an estimated $28,055,694
- MACKENZIE FINANCIAL CORP added 745,778 shares (+105.2%) to their portfolio in Q3 2025, for an estimated $26,616,816
- UBS GROUP AG added 532,530 shares (+129.3%) to their portfolio in Q3 2025, for an estimated $19,005,995
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 524,766 shares (+34.3%) to their portfolio in Q3 2025, for an estimated $18,728,898
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
